# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001367644-21-000112
Filing Date
2021-07-29
Accepted
2021-07-29 16:26:27
Documents
42
Period of Report
2021-07-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | ebs-20210729.htm iXBRL | 8-K | 37760
2 | EX-99.1 | ebs2021-06x30ex99earningsr.htm | EX-99.1 | 329433
3 | EX-99.2 | ebs_investorq22021update.htm | EX-99.2 | 30070
4 | EX-99.3 | emergentbiosolutionstore.htm | EX-99.3 | 5875
8 | GRAPHIC | ebs_investorq22021update001.jpg | GRAPHIC | 56385
9 | GRAPHIC | ebs_investorq22021update002.jpg | GRAPHIC | 53209
10 | GRAPHIC | ebs_investorq22021update003.jpg | GRAPHIC | 278621
11 | GRAPHIC | ebs_investorq22021update004.jpg | GRAPHIC | 159611
12 | GRAPHIC | ebs_investorq22021update005.jpg | GRAPHIC | 47883
13 | GRAPHIC | ebs_investorq22021update006.jpg | GRAPHIC | 59108
14 | GRAPHIC | ebs_investorq22021update007.jpg | GRAPHIC | 177747
15 | GRAPHIC | ebs_investorq22021update008.jpg | GRAPHIC | 62868
16 | GRAPHIC | ebs_investorq22021update009.jpg | GRAPHIC | 99250
17 | GRAPHIC | ebs_investorq22021update010.jpg | GRAPHIC | 65684
18 | GRAPHIC | ebs_investorq22021update011.jpg | GRAPHIC | 96439
19 | GRAPHIC | ebs_investorq22021update012.jpg | GRAPHIC | 115854
20 | GRAPHIC | ebs_investorq22021update013.jpg | GRAPHIC | 98389
21 | GRAPHIC | ebs_investorq22021update014.jpg | GRAPHIC | 108592
22 | GRAPHIC | ebs_investorq22021update015.jpg | GRAPHIC | 113452
23 | GRAPHIC | ebs_investorq22021update016.jpg | GRAPHIC | 67151
24 | GRAPHIC | ebs_investorq22021update017.jpg | GRAPHIC | 42873
25 | GRAPHIC | ebs_investorq22021update018.jpg | GRAPHIC | 52480
26 | GRAPHIC | ebs_investorq22021update019.jpg | GRAPHIC | 177569
27 | GRAPHIC | ebs_investorq22021update020.jpg | GRAPHIC | 100640
28 | GRAPHIC | ebs_investorq22021update021.jpg | GRAPHIC | 87133
29 | GRAPHIC | ebs_investorq22021update022.jpg | GRAPHIC | 92356
30 | GRAPHIC | ebs_investorq22021update023.jpg | GRAPHIC | 90889
31 | GRAPHIC | ebs_investorq22021update024.jpg | GRAPHIC | 83491
32 | GRAPHIC | emergentbiosolutionstore001.jpg | GRAPHIC | 254658
33 | GRAPHIC | emergentbiosolutionstore002.jpg | GRAPHIC | 27954
34 |  | image2.gif | GRAPHIC | 6381
| Complete submission text file | 0001367644-21-000112.txt |  | 4277446

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | ebs-20210729.xsd | EX-101.SCH | 1965
6 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | ebs-20210729_lab.xml | EX-101.LAB | 25154
7 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | ebs-20210729_pre.xml | EX-101.PRE | 13100
35 | EXTRACTED XBRL INSTANCE DOCUMENT | ebs-20210729_htm.xml | XML | 11294

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33137 | Film No.: 211127817
SIC: 2834 Pharmaceutical Preparations